Find valuable ACTEMRA® (tocilizumab) information, including an ACTEMRA® dosing calculator, RA patient brochure, ACTEMRA® prescription guide and the. Tocilizumab (Actemra) is a biologic reference guide with prescribing information, dosage, medication administration, and possible side effects. Each vial contains 80 mg of tocilizumab* in 4 ml (20 mg/ml). . Dose interruptions of tocilizumab for the following laboratory abnormalities are recommended in.

Author: Turamar Tar
Country: Bosnia & Herzegovina
Language: English (Spanish)
Genre: Technology
Published (Last): 1 March 2004
Pages: 321
PDF File Size: 4.67 Mb
ePub File Size: 16.19 Mb
ISBN: 337-1-85622-935-5
Downloads: 53781
Price: Free* [*Free Regsitration Required]
Uploader: JoJogore

Tell your healthcare provider if you have these or any other side effect that bothers you or does not go away:. However, if the patient has a history of prior acute infusion reaction, monitor actemra prescribing information signs every 10 minutes for 30 minutes and for 30 minutes after the infusion.

Please select a treatment to continue

Adding plans allows you to compare formulary status to other drugs in the same class. This can make a patient more likely to get infections or make any current infection worse. Informatoin monitoring — recommended due to potential consequences of treatment-related changes in neutrophils, platelets, lipids and liver specific enzymes.

QL Quantity Limits Drugs that have quantity limits associated with each prescription. Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with ACTEMRA, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating actfmra. Pregnancy exposure registry that monitors pregnancy outcomes actemra prescribing information women exposed to during pregnancy; patients and pregnant women are encouraged to prescriging themselves actemra prescribing information calling Patients must tell their doctor if they have these or any other side effect that bothers them or does not go away: Patients must tell their doctor right away if they are experiencing any side effects.

Hypersensitivity reactions including actemra prescribing information and death.

Related Posts  ASTM F1941 EPUB DOWNLOAD

Actemra (tocilizumab) dosing, indications, interactions, adverse effects, and more.

This drug is available at a higher level co-pay. Abatacept Orencia Medication Guide: Actemra prescribing information may also report side effects to Genentech at Patients must tell their doctor if they have these actemra prescribing information any other side effect that bothers them or does not go away:.

The rate of serious infections was 9. No physical or biochemical informatin studies actemrz been conducted to evaluate the coadministration of tocilizumab with other drugs. Infection signs, with or without a fever, include sweating or chills; shortness of breath; warm, red or painful skin or sores on your body; feeling very tired; muscle aches; blood in phlegm; diarrhea or stomach pain; cough; weight loss; burning when you urinate or urinating more often than normal Any actemra prescribing information the following conditions that may give you a higher chance of getting infections.

Prescribers should exercise caution in considering the use of ACTEMRA in patients with preexisting or recent-onset demyelinating xctemra.

Administer first SC dose instead of the next scheduled IV dose. Shortness of breath or trouble breathing Swelling of lips, tongue, or face Chest pain Feeling dizzy or faint Moderate or severe abdominal actemra prescribing information or vomiting. Tocilizumab Actemra Medication Guide: Dilute to 50 mL in 0.

There was no clear relationship between decreases in neutrophils below 1 x 10 9 actemra prescribing information L and the occurrence of serious infections. Anaphylaxis and other hypersensitivity reactions that required treatment discontinuation were reported in 0.

Actemra prescribing information learn more, call or talk to your healthcare provider to register. You may also call Genentech at This restriction requires that specific clinical criteria predcribing met prior to the approval of the prescription.

This restriction typically limits the quantity of the drug that will be covered. You should not do both. These elevations did not result in apparent permanent or clinically evident hepatic injury in clinical trials. Do not actemra prescribing information vials until after successfully obtaining intravenous access.


During the 1-year study, a frequency of Impact of treatment with tocilizumab on demyelinating disorders is unknown, but multiple sclerosis and chronic inflammatory demyelinating polyneuropathy were reported rarely in Actemra prescribing information clinical studies; monitor for signs and symptoms potentially indicative of demyelinating disorders.

Resume mg at every other week and increase frequency to every week as clinically appropriate. The rate of actemra prescribing information was Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.

Axtemra the supervising provider of the reaction. Adults with moderately to severely active rheumatoid arthritis, or RA. Most common side effects Tell your healthcare provider if you have these or any ifnormation side effect actemra prescribing information bothers you or does not go away: Tell your healthcare provider if you have informationn or any other side effect that bothers you or does not go away: Click “OK” if you are a healthcare professional.

Increased frequency and magnitude of these elevations was actemra prescribing information when potentially hepatotoxic drugs e. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Tell your healthcare provider right away if peescribing are experiencing any side effects.

Recommended overview Procedures. Tocilizumab has not been studied in combination with biological DMARDs eg, TNF antagonists, IL-1R antagonists, anti-CD20 monoclonal antibodies, selective costimulation modulators and its use should be avoided actemra prescribing information combination ingormation these agents because of increased immunosuppression and risk of infection.

Instruct the patient to remove from the refrigerator approximately minutes prior to injection. Your list will be saved and can be edited at any time.